Published in Pain on August 01, 1995
A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials. Eur J Clin Pharmacol (2006) 1.42
Assessing efficacy of non-opioid analgesics in experimental pain models in healthy volunteers: an updated review. Br J Clin Pharmacol (2009) 1.16
A simple pain model for the evaluation of analgesic effects of NSAIDs in healthy subjects. Br J Clin Pharmacol (2003) 0.96
Hyperalgesia induced by cutaneous freeze injury for testing analgesics in healthy volunteers. Br J Clin Pharmacol (2006) 0.94
Translating nociceptive processing into human pain models. Exp Brain Res (2009) 0.93
Cold suppresses agonist-induced activation of TRPV1. J Dent Res (2011) 0.84
Anti-inflammatory and antihyperalgesic effects of the combination of ibuprofen and hemin in adjuvant-induced arthritis in the Wistar rat. Inflammopharmacology (2011) 0.82
More sensory competence for nociceptive neurons in culture. Proc Natl Acad Sci U S A (1996) 0.81
A novel model of inflammatory pain in human skin involving topical application of sodium lauryl sulfate. Inflamm Res (2010) 0.78
[Modulation of cortical pain processing by cyclooxygenase inhibition: a functional MRI study]. Schmerz (2009) 0.77
Sensitivity of repeated interdigital web pinching to detect antinociceptive effects of ibuprofen. Br J Clin Pharmacol (2000) 0.75
A literature review on the pharmacological sensitivity of human evoked hyperalgesia pain models. Br J Clin Pharmacol (2016) 0.75
Investigation of the predictive validity of laser-EPs in normal, UVB-inflamed and capsaicin-irritated skin with four analgesic compounds in healthy volunteers. Br J Clin Pharmacol (2017) 0.75
[Differentiation of peripheral and central hyperalgesic effects of systemic procaine]. Schmerz (2004) 0.75
[Pharmacological aspects of pain research in Germany]. Schmerz (2015) 0.75
Tau suppression in a neurodegenerative mouse model improves memory function. Science (2005) 8.66
Specific C-receptors for itch in human skin. J Neurosci (1997) 3.51
Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J (2001) 2.52
Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens. J Neurophysiol (2003) 2.39
Nervous outflow from the cat's foot during noxious radiant heat stimulation. Brain Res (1974) 2.18
Protons selectively induce lasting excitation and sensitization to mechanical stimulation of nociceptors in rat skin, in vitro. J Neurosci (1992) 2.17
Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrations. J Rheumatol (1995) 2.09
Bradykinin and serotonin effects on various types of cutaneous nerve fibers. Pflugers Arch (1974) 2.07
COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. FASEB J (2001) 1.97
Novel classes of responsive and unresponsive C nociceptors in human skin. J Neurosci (1995) 1.97
Assessment of phagocytic and antimicrobial activity of human granulocytes. Infect Immun (1974) 1.96
Quantitative detection of Borrelia burgdorferi by real-time PCR. J Clin Microbiol (1999) 1.93
The venous graft as an effector of early angiogenesis in a fibrin matrix. Microvasc Res (2007) 1.93
Women encounter ADRs more often than do men. Eur J Clin Pharmacol (2008) 1.83
Responsiveness and functional attributes of electrically localized terminals of cutaneous C-fibers in vivo and in vitro. J Neurophysiol (1992) 1.82
Functional attributes discriminating mechano-insensitive and mechano-responsive C nociceptors in human skin. J Neurosci (1999) 1.61
Which nerve fibers mediate the axon reflex flare in human skin? Neuroreport (2000) 1.60
Gastrointestinal ulcerations induced by anti-inflammatory drugs in rats. Physicochemical and biochemical factors involved. Arch Toxicol (1990) 1.59
Left vagus nerve stimulation suppresses experimentally induced pain. Neurology (2000) 1.57
Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf (2000) 1.51
Chemosensitivity of fine afferents from rat skin in vitro. J Neurophysiol (1990) 1.48
Parameters of thick and thin nerve-fiber functions as predictors of pain in carpal tunnel syndrome. Pain (1995) 1.45
Complex regional pain syndrome: how to resolve the complexity? Pain (2001) 1.45
Pharmacological control of prostaglandin and thromboxane release from macrophages. Nature (1978) 1.44
Discharge patterns of human C-fibers induced by itching and burning stimuli. J Neurophysiol (1991) 1.42
Readmissions and adverse drug reactions in internal medicine: the economic impact. J Intern Med (2004) 1.42
Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am J Pathol (2000) 1.42
Segmental and supraspinal actions on dorsal horn neurons responding to noxious and non-noxious skin stimuli. Pain (1975) 1.39
Peroxidaseless chicken leukocytes: isolation and characterization of antibacterial granules. J Infect Dis (1973) 1.39
Encoding of burning pain from capsaicin-treated human skin in two categories of unmyelinated nerve fibres. Brain (2000) 1.37
Response properties of thin myelinated (A-delta) fibers in human skin nerves. J Neurophysiol (1983) 1.36
Inhibition of anti-inflammatory drugs of prostaglandin production in cultured macrophages. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.36
Leukocytes and prostaglandins in acute inflammation. Experientia (1974) 1.35
Pharmacokinetics of opioids in liver disease. Clin Pharmacokinet (1999) 1.32
BOLD fMRI deactivation of limbic and temporal brain structures and mood enhancing effect by transcutaneous vagus nerve stimulation. J Neural Transm (Vienna) (2007) 1.31
Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett (1996) 1.30
Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc Natl Acad Sci U S A (1998) 1.30
Elevated serum cyclophilin levels in patients with severe sepsis. J Clin Immunol (1997) 1.28
The effect of capsaicin application to a peripheral nerve on impulse conduction in functionally identified afferent nerve fibres. Brain Res (1983) 1.27
The effect of carrageenan-induced inflammation on the sensitivity of unmyelinated skin nociceptors in the rat. Pain (1987) 1.24
Computerized surveillance of adverse drug reactions in hospital: implementation. Eur J Clin Pharmacol (1999) 1.24
Psychophysical examination of pain induced by defined CO2 pulses applied to the nasal mucosa. Pain (1992) 1.24
Selective excitation by capsaicin of mechano-heat sensitive nociceptors in rat skin. Brain Res (1988) 1.22
Time course of post-excitatory effects separates afferent human C fibre classes. J Physiol (2000) 1.22
Activation of neurons in rat trigeminal subnucleus caudalis by different irritant chemicals applied to oral or ocular mucosa. J Neurophysiol (1998) 1.20
Unmyelinated nociceptive units in two skin areas of the rat. Brain Res (1983) 1.18
Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-kappaB. FASEB J (2001) 1.18
Delayed responses to electrical stimuli reflect C-fiber responsiveness in human microneurography. Exp Brain Res (1995) 1.18
Discharge patterns of afferent cutaneous nerve fibers from the rat's tail during prolonged noxious mechanical stimulation. Exp Brain Res (1987) 1.17
Possible role of oxygen free radicals in ethanol-induced gastric mucosal damage in rats. Dig Dis Sci (1988) 1.17
Inhibition of cyclooxygenases by dipyrone. Br J Pharmacol (2007) 1.14
Excitation of cutaneous afferent nerve endings in vitro by a combination of inflammatory mediators and conditioning effect of substance P. Exp Brain Res (1992) 1.13
A comparison between the discharges of human nociceptive nerve fibres and the subject's ratings of his sensations. J Physiol (1979) 1.13
Characteristics of C-fibre receptors in the cat's foot responding to stepwise increase of skin temperature ot noxious levels. Pflugers Arch (1976) 1.12
Biodistribution of mild analgesics. Br J Clin Pharmacol (1980) 1.12
Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet. Clin Pharmacol Ther (2002) 1.12
Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation. J Thromb Haemost (2011) 1.11
Acidic nonsteroid anti-inflammatory drugs accumulating in inflamed tissue. Experientia (1975) 1.11
Risk factor assessment of endoscopically removed malignant colorectal polyps. Gut (1998) 1.11
Cyclooxygenase 2 expression in the spared nerve injury model of neuropathic pain. Neuroscience (2004) 1.10
Microbicidal activity of peroxidaseless chicken heterophile leukocytes. Infect Immun (1972) 1.10
Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals. Br J Clin Pharmacol (1999) 1.10
Correlation between antimicrobial activity and peroxidase content of leukocytes. Nature (1973) 1.10
Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method. Br J Anaesth (1993) 1.10
Effects of antihyperalgesic drugs on experimentally induced hyperalgesia in man. Pain (1998) 1.10
Properties of transdermal histamine iontophoresis: differential effects of season, gender, and body region. J Invest Dermatol (1990) 1.09
Automatic classification and analysis of microneurographic spike data using a PC/AT. J Neurosci Methods (1990) 1.09
The effect of age on the pharmacokinetics and pharmacodynamics of midazolam. Clin Pharmacol Ther (1999) 1.08
Prostaglandin E(2) upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages. Biochem Biophys Res Commun (2000) 1.08
Prostaglandin release from macrophages: an assay system for anti-inflammatory drugs in vitro. Agents Actions (1977) 1.08
Effect of anti-inflammatory and analgesic pyrazoles on arachidonic acid metabolism in isolated heart and gastric mucosa preparations. Agents Actions Suppl (1986) 1.07
Effects of pentazocine and acetylsalicylic acid on pain-rating, pain-related evoked potentials and vigilance in relationship to pharmacokinetic parameters. Agents Actions (1990) 1.06
Factors associated with coronary artery calcification in young female patients with SLE. Ann Rheum Dis (2003) 1.05
Stereoselective disposition of flurbiprofen in healthy subjects following administration of the single enantiomers. Br J Clin Pharmacol (1994) 1.05
Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs. A survey of their analgesic efficacy. Drugs (1991) 1.04
Microneurographic assessment of C-fibre function in aged healthy subjects. J Physiol (2008) 1.04
Cyclooxygenase-2 immunoreactivity in the human brain following cerebral ischemia. Acta Neuropathol (1999) 1.04
Vascular reactions correlated with pain due to cold. Exp Neurol (1984) 1.03
Results of surgery in patients with refractory extratemporal epilepsy with normal or nonlocalizing magnetic resonance findings investigated with subdural grids. Epilepsia (2001) 1.03
Innervation territories of mechanically activated C nociceptor units in human skin. J Neurophysiol (1997) 1.03
Active "itch fibers" in chronic pruritus. Neurology (2003) 1.02
Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons. Eur J Pharmacol (1992) 1.02
The transfer half-life of morphine-6-glucuronide from plasma to effect site assessed by pupil size measurement in healthy volunteers. Anesthesiology (2001) 1.02
Pure enantiomers of 2-arylpropionic acids: tools in pain research and improved drugs in rheumatology. J Clin Pharmacol (1992) 1.02
Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration. Clin Pharmacol Ther (1999) 1.01
Interleukin-1beta induces chronic activation and de novo synthesis of neutral ceramidase in renal mesangial cells. J Biol Chem (2001) 1.01
Serum antibodies against chondrocyte cell surface proteins in osteoarthritis and rheumatoid arthritis. J Rheumatol (1988) 1.01
Effects of selective COX-1 and -2 inhibition on formalin-evoked nociceptive behaviour and prostaglandin E(2) release in the spinal cord. J Neurochem (2001) 1.00
Angiotensin-(1-7) and the rat aorta: modulation by the endothelium. J Cardiovasc Pharmacol (1997) 1.00
The ability of humans to localise noxious stimuli. Neurosci Lett (1993) 1.00